BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.870
0.00 (0.00%)
Jan 14, 2026, 4:00 PM EST - Market closed
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $12.41 million as of January 15, 2026. Its market cap has decreased by -47.18% in one year.
Market Cap
12.41M
Enterprise Value
-2.11M
1-Year Change
-47.18%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $12.41M, a decrease of -63.28%. That is a compound annual growth rate of -5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 12.41M | -5.27% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |